Approved Products
| LICENSEE/PARTNER |
PRODUCT NAME |
GENERIC NAME |
PRIMARY INDICATION |
MARKETED |
| INHALATION |
| AstraZeneca |
Pulmicort® HFA-MDI
|
budesonide |
Asthma |
yes |
| ORAL |
| sanofi-aventis |
Xatral® OD/ Uroxatral®
|
alfuzosin |
BPH (urinary symptoms) |
yes |
| GlaxoSmithKline |
Requip® Once-a-day
|
ropinirole |
Parkinson’s disease |
yes |
| GlaxoSmithKline |
Paxil CR™
|
paroxetine |
Depression |
yes |
| Sciele Pharma (Shionogi) |
Triglide®
|
fenofibrate |
Lipid disorders |
yes |
| Sciele Pharma (Shionogi) |
Sular®
|
nisoldipine |
Hypertension |
yes |
| Roche |
Madopar DR®
|
levodopa + benserazide |
Parkinson’s disease |
yes |
| Cornerstone Therapeutics |
ZYFLO CR®
|
zileuton |
Asthma |
yes |
| Therabel |
Coruno®
|
molsidomine |
Angina |
yes |
| Ratiopharm |
diclofenac-ratiopharm® uno
|
diclofenac |
Pain/inflammation |
yes |
| Nitec Europe |
Lodotra®
|
prednisone |
Rheumatoid arthritis |
yes |
| TOPICAL |
| Nycomed/Almirall |
Solaraze®
|
diclofenac |
Actinic keratosis |
yes |
Copyright 2009, SkyePharma. All Rights Reserved.
SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom